Healthcare provider profile · identity verified

Christopher J. Crossland, MD

Family Practice · ROHNERT PARK, CA · NPI 1447334438

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	481	163
Levothyroxine Sodium	Levothyroxine Sodium	339	106
Losartan Potassium	Losartan Potassium	328	109
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	278	48
Lisinopril	Lisinopril	246	81
Amlodipine Besylate	Amlodipine Besylate	220	79
Pantoprazole Sodium	Pantoprazole Sodium	181	64
Albuterol Sulfate Hfa	Albuterol Sulfate	180	106
Fluticasone Propionate	Fluticasone Propionate	180	58
Tamsulosin Hcl	Tamsulosin Hcl	140	53
Metoprolol Tartrate	Metoprolol Tartrate	137	48
Famotidine	Famotidine	136	63
Hydrochlorothiazide	Hydrochlorothiazide	135	49
Simvastatin	Simvastatin	112	42
Omeprazole	Omeprazole	104	35
Gabapentin	Gabapentin	103	45
Trazodone Hcl	Trazodone Hcl	102	36
Terazosin Hcl	Terazosin Hcl	100	28
Pravastatin Sodium	Pravastatin Sodium	93	29
Furosemide	Furosemide	89	35
Potassium Chloride	Potassium Chloride	87	34
Lorazepam	Lorazepam	85	23
Metoprolol Succinate	Metoprolol Succinate	83	35
Triamcinolone Acetonide	Triamcinolone Acetonide	82	33
Duloxetine Hcl	Duloxetine Hcl	81	30
Glipizide	Glipizide	73	26
Metformin Hcl Er	Metformin Hcl	72	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	27
Carvedilol	Carvedilol	68	19
Clopidogrel	Clopidogrel Bisulfate	66	17
Morphine Sulfate Er	Morphine Sulfate	65	suppressed
Alvesco	Ciclesonide	62	25
Montelukast Sodium	Montelukast Sodium	58	22
Meloxicam	Meloxicam	57	23
Allopurinol	Allopurinol	56	23
Atenolol	Atenolol	56	20
Rosuvastatin Calcium	Rosuvastatin Calcium	56	23
Wixela Inhub	Fluticasone Propion/Salmeterol	55	19
Baclofen	Baclofen	52	14
Ozempic	Semaglutide	51	12
Humulin N	Insulin Nph Human Isophane	48	13
Acyclovir	Acyclovir	47	20
Cefadroxil	Cefadroxil	46	38
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	15
Fluoxetine Hcl	Fluoxetine Hcl	46	16
Pradaxa	Dabigatran Etexilate Mesylate	46	20
Amoxicillin	Amoxicillin	42	29
Bisoprolol Fumarate	Bisoprolol Fumarate	41	15
Lovastatin	Lovastatin	41	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	suppressed
Alendronate Sodium	Alendronate Sodium	39	12
Finasteride	Finasteride	39	13
Topiramate	Topiramate	38	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	33
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	36	13
Clonazepam	Clonazepam	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	35	suppressed
Methocarbamol	Methocarbamol	35	12
Mirtazapine	Mirtazapine	33	11
Nortriptyline Hcl	Nortriptyline Hcl	33	13
Azithromycin	Azithromycin	30	24
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Ibuprofen	Ibuprofen	29	11
Metformin Hcl	Metformin Hcl	29	12
Sertraline Hcl	Sertraline Hcl	29	12
Azelastine Hcl	Azelastine Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	27	suppressed
Eliquis	Apixaban	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	11
Breyna	Budesonide/Formoterol Fumarate	25	15
Propranolol Hcl	Propranolol Hcl	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	12
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	24	24
Jardiance	Empagliflozin	24	11
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Ketoconazole	Ketoconazole	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Cephalexin	Cephalexin	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	21	suppressed
Ciclopirox	Ciclopirox	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Humulin R	Insulin Regular, Human	19	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	19	suppressed
Naproxen	Naproxen	19	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	18	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	18	15
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Estradiol	Estradiol	17	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	17	17
Methenamine Hippurate	Methenamine Hippurate	16	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	16	suppressed
Mupirocin	Mupirocin	16	16
Nabumetone	Nabumetone	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Prednisone	Prednisone	16	12
Temazepam	Temazepam	16	suppressed
Trospium Chloride	Trospium Chloride	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Diazepam	Diazepam	14	suppressed
Digoxin	Digoxin	14	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	14	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Colchicine	Colchicine	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Victoza 2-Pak	Liraglutide	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Clonidine	Clonidine	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nystatin	Nystatin	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error